Titelia

Holdings of BAKER BROS. ADVISORS LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
74 in 5 countries
Top ten
77.7 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Incyte Corp 30,744,4122.9B $
2BEONE MEDICINES LTD 8,799,0532.6B $
3Insmed Inc 7,421,1111.2B $
4Madrigal Pharmaceuticals Inc 2,141,7011.1B $
5ACADIA Pharmaceuticals Inc 42,896,690954.9M $
6Revolution Medicines Inc 9,555,357929.3M $
7Celcuity Inc 7,915,792903.5M $
8Kodiak Sciences Inc 19,919,186759.3M $
9Kymera Therapeutics Inc 8,657,242721.1M $
10Summit Therapeutics Inc 36,391,063690M $
11Praxis Precision Medicines Inc 1,753,198564.9M $
12Rhythm Pharmaceuticals Inc 5,604,483487.4M $
13GRAIL Inc 4,028,614208.2M $
14Edgewise Therapeutics Inc 6,575,940207.1M $
15Ionis Pharmaceuticals Inc 2,047,727153.8M $
16Immunovant Inc 5,457,881135.6M $
17Ideaya Biosciences Inc 3,946,515131.5M $
18Arrowhead Pharmaceuticals Inc 1,992,783124.9M $
19Stoke Therapeutics Inc 3,336,697108.6M $
20Abivax SA 875,79697.5M $
21Crinetics Pharmaceuticals Inc 2,351,46585.4M $
22Replimune Group Inc 11,045,33684.5M $
23Nurix Therapeutics Inc 4,658,55672.2M $
24Denali Therapeutics Inc 3,731,69571.6M $
25Dianthus Therapeutics Inc 852,16471.5M $
26Monte Rosa Therapeutics Inc 4,345,73671.5M $
27Structure Therapeutics Inc 1,432,52969M $
28Entrada Therapeutics Inc 5,072,73064M $
29Bicycle Therapeutics PLC 10,885,35750.5M $
30Spyre Therapeutics Inc 1,000,00050.4M $
31Rapport Therapeutics Inc 1,547,09048.4M $
32Alumis Inc 2,012,50044.3M $
33Mirum Pharmaceuticals Inc 445,97541.2M $
34Viridian Therapeutics Inc 1,971,67838.6M $
35Enliven Therapeutics Inc 905,19135.5M $
36Prelude Therapeutics Inc 10,123,82434.6M $
37DBV Technologies SA 1,461,42530.5M $
38Design Therapeutics Inc 2,585,97827.5M $
39CENTESSA PHARMACEUTICALS PLC 670,75126.6M $
40CytomX Therapeutics Inc 4,975,82623.4M $
41JADE BIOSCIENCES INC 1,641,13723.1M $
42Disc Medicine Inc 349,65722.4M $
43Immunocore Holdings PLC 734,39722.1M $
44Celldex Therapeutics Inc 665,37021.1M $
45Neurogene Inc 991,69120M $
46Evommune Inc 847,39019.5M $
47Tectonic Therapeutic Inc 607,78818.8M $
48Contineum Therapeutics Inc 1,420,83818.6M $
49Argenx SE 25,17418.4M $
50Cerus Corp 10,008,34518.2M $
51Taysha Gene Therapies Inc 4,004,75617.9M $
52Aktis Oncology Inc 996,35117.8M $
53Generate Biomedicines Inc 1,423,60217.8M $
54Sionna Therapeutics Inc 400,00016M $
55Dyne Therapeutics Inc 813,44914.7M $
56Xencor Inc 1,102,10613.3M $
57Compass Pathways plc 2,344,72013M $
58Relay Therapeutics Inc 1,160,11711.5M $
59Sera Prognostics Inc 5,498,17011.2M $
60BioNTech SE 119,74310.6M $
61Arcus Biosciences Inc 415,6219M $
62MapLight Therapeutics Inc 364,7057.4M $
63Absci Corp 2,134,8036.4M $
64VTV THERAPEUTICS INC 148,3145.9M $
65Eikon Therapeutics Inc 555,5555.9M $
66Protara Therapeutics Inc 971,6145.1M $
67Sagimet Biosciences Inc 952,9965M $
68LB Pharmaceuticals Inc 200,0004.9M $
69Verastem Inc 584,7573.1M $
70TScan Therapeutics Inc 2,784,7922.8M $
71SKYE BIOSCIENCE INC 1,575,243968.1K $
72Sana Biotechnology Inc 310,483894.2K $
73Aligos Therapeutics Inc 83,055617.1K $
74Tyra Biosciences Inc 10,607406.2K $

Download this table: CSV, JSON

Sector breakdown

  • Health care 26.0 %
  • Unattributed 74.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 98.7 %
  • France 0.8 %
  • United Kingdom 0.4 %
  • Netherlands 0.1 %
  • Germany 0.1 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States6816.2B $98.66 %
2France2128M $0.78 %
3United Kingdom263.5M $0.39 %
4Netherlands118.4M $0.11 %
5Germany110.6M $0.06 %
Cite this page

Titelia. "Holdings of BAKER BROS. ADVISORS LP". https://titelia.com/en/funds/US13F1263508